Compare plasmid vectors and viral vectors in gene delivery, noting a key advantage of each.

• A. Plasmids are safe for in vivo use; viral vectors are simple and inexpensive.
• B. Plasmids are simple and safe for in vitro use; viral vectors offer high efficiency in vivo but require safety considerations.
• C. Plasmids integrate into the genome; viral vectors never integrate.
• D. Plasmids have higher delivery efficiency in vivo than viral vectors.

Answer: (B)

A key idea here is comparing non-viral plasmid vectors with viral vectors for gene delivery and linking their practical strengths to typical use settings. Plasmid vectors are straightforward to construct and can be introduced into cultured cells with relatively simple methods, making them a convenient and safe option for in vitro experiments. They usually don’t involve viral components, so they tend to have lower biosafety concerns and immunogenicity in a controlled lab setting, and expression is often transient.

Viral vectors, by contrast, are engineered to exploit natural viral entry and gene delivery mechanisms, which yields high efficiency in delivering genetic material in vivo. This makes them especially powerful for delivering genes to tissues inside a living organism. However, because they are derived from viruses, they bring safety considerations: potential immune responses, tissue targeting and tropism issues, and, depending on the vector, risks related to integration into the host genome or other biosafety and manufacturing complexities.

So the statement aligns with the general trade-offs: plasmids are simple and safe for in vitro use, while viral vectors offer high delivery efficiency in vivo but require careful safety considerations.